BEIJING – The hot topic at this year's China Bio International 2014 is what type of strategy drugmakers should take to get innovative drugs on the market with China's challenging biologics manufacturing rules. It's clearly a high-stakes gamble, with innovators betting on one of three different horses to get them to the finish line.